CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.
Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Semaglutide is a synthetic GLP-1 analogue developed as a long-acting prescription medicine. Authorised products have substantial clinical evidence for specific labelled indications, but their results and quality standard cannot be assumed for an unverified catalogue vial.
Research focus
GLP-1 receptor signalling in defined metabolic and cardiovascular settings.
Current evidence context
Large controlled trials support authorised semaglutide products for defined indications. That evidence does not prove longevity, does not apply to every formulation, and does not verify the identity or sterility of supplier material.
Questions this record follows
How do metabolic outcomes vary by population and authorised formulation?
Which benefits and adverse effects persist during longer follow-up?
How do validated cardiovascular and metabolic endpoints relate to treatment exposure?
Follow the sources
Registry entries identify reference substances. Literature links describe research and do not certify this product or its batch.
Exact CELLIVITY-batch review is pending. Reference files below describe their own declared samples.
Purity, identity, per-vial content and sterility are separate results.
Product
Semaglutide
Record
CEL-P-SEM-001
Files received
0
0 FILES
No product-specific laboratory file has been uploaded yet.
AVAILABILITY
Tell us what your lab needs.
Request current availability for a lawful institutional, analytical or laboratory purpose. We confirm the exact presentation, price, batch and document state before any next step.
Exact presentation review
Jurisdiction and purpose check
Batch-document confirmation
No medical or human-use guidance
SELECTED PRODUCTSemaglutideCEL-P-SEM-001 · response after manual review
Semaglutide: before you enquire
What exactly does the selected format mean?＋
The mg or IU value is the declared material content per vial; it is not the container volume. Your selected presentation and quantity are saved with your enquiry. The final price is confirmed in the response.
Which batch will be supplied?＋
The specific batch and its documents are confirmed in the response. Files shown here may be supplier reference samples; the current record does not yet contain a qualified CELLIVITY lot dossier.
When can it arrive in Thailand?＋
For confirmed local stock, the planned window is 2–3 working days in Thailand. Pattaya timing is agreed directly. Incoming or specially sourced products have a separate estimate, confirmed before a commitment.
Can I enquire about several products together?＋
Yes. Add each format and quantity to the cart, then send one availability enquiry. Your selected items are kept together for review.
CELLIVITY
Semaglutide
CEL-P-SEM-001 · 10 mg
Semaglutide is a synthetic GLP-1 analogue developed as a long-acting prescription medicine. Authorised products have substantial clinical evidence for specific labelled indications, but their results and quality standard cannot be assumed for an unverified catalogue vial.
GLP-1 receptor signalling in defined metabolic and cardiovascular settings.
Other names
NN9535 · NNC 0113-0217 · semaglutide
PubChem CID
56843331
CAS number
910463-68-2
Molecular formula
C187H291N45O59
Molecular weight
4114 g/mol
Peptide length
31 amino acids
Compound class
Long-acting synthetic GLP-1 analogue
Follow the sources
Large controlled trials support authorised semaglutide products for defined indications. That evidence does not prove longevity, does not apply to every formulation, and does not verify the identity or sterility of supplier material.
How do metabolic outcomes vary by population and authorised formulation?
Which benefits and adverse effects persist during longer follow-up?
How do validated cardiovascular and metabolic endpoints relate to treatment exposure?
Lab documents
CELLIVITY lot review pending
No lab files received
A known molecule name does not make a non-authorised presentation equivalent to an approved medicine.
